Astrana Health (ASTH) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.71
- Estimate
- $0.88
- Surprise
- -19.0%
- Score today
- 5.3/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Astrana Health (ASTH) missed the $0.88 estimate with adjusted EPS of $0.71 — a large 19.0% shortfall.
Coverage in the report window
- Needham Maintains Buy on Astrana Health, Raises Price Target to $45 — benzinga, 2026-11-06
- Astrana Health Q3 2026 Earnings Call Transcript — benzinga, 2026-11-05
- Astrana Health Reports Q3 2026 Financial Results and Provides Q4 Outlook — fiscal.ai, 2026-11-05
Where TrendMatrix's rating stands now
TrendMatrix currently rates ASTH Sell at 5.3/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's -19.0% surprise compares with a +8.3% four-quarter average. Next scheduled report: 2027-03-01.
What argues against it
- Quality below floor (3.8 < 4.0)
- Value-trap signals (2/5): Margin compression (op margin 1.7%), High leverage (D/E 27.9)
- Momentum score 4.1/10 — below 4.5 minimum
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $34.50
- Price target
- $44.95
- Stop
- $32.09
- Upside to target
- +30.3%
- Reward-to-risk
- 2.5:1
The stock trades at 31.9× trailing but 9.5× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 3.2× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-07 — shown for context, not personalized investment advice.
ASTH at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Care Facilities
- Market cap
- $1.71B
- P/E (fwd)
- 9.5
- P/E (ttm)
- 31.9
- 52-week range
- $18.08–$51.60
- Off 52-week high
- 33.1%
- RSI (14)
- 41
- Volume vs avg
- 3.17×
- Score today
- 5.3/10